Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer - Scorecard - MDSpire

Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer

  • By

  • Agata Świętek

  • Joanna K. Strzelczyk

  • Dorota Hudy

  • Zenon P. Czuba

  • Karolina Snopek-Miśta

  • Mariusz Kryj

  • Katarzyna Kuśnierz

  • Marcin Zeman

  • Malgorzata Oczko-Wojciechowska

  • Daria Handkiewicz-Junak

  • Janusz Strzelczyk

  • July 2, 2026

  • 0 min

Share

Clinical Scorecard: Significant Impact of IL-6, IL-8, IL-11, and Leptin on Tumor Microenvironment in Patients with GEP-NETs: Interplay Between Inflammation and Cancer

At a Glance

CategoryDetail
ConditionGastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Key MechanismsCytokines IL-6, IL-8, IL-11, and leptin involved in tumor growth and metastatic potential.
Target PopulationPatients diagnosed with GEP-NETs.
Care SettingOncological surgery departments in Poland.

Key Highlights

  • Higher concentrations of IL-6, IL-8, IL-11, and leptin found in tumor samples compared to surgical margins.
  • IL-6 and leptin levels significantly elevated in T4 tumors.
  • Cytokine levels varied by tumor localization (pancreatic, ileal, colonic, small intestine).
  • Altered leptin patterns associated with smoking exposure.
  • Cytokines correlated with comorbidities and clinical variables.

Guideline-Based Recommendations

Diagnosis

  • Assessment of cytokine levels may provide insights into GEP-NET pathophysiology.

Management

  • Further studies needed to explore the potential biomarker value of cytokines.

Monitoring & Follow-up

  • Monitor cytokine levels in relation to tumor staging and patient demographics.

Risks

  • Elevated IL-6 levels correlated with poor prognosis in malignancies.

Patient & Prescribing Data

59 patients with GEP-NETs.

Cytokine profiling may aid in refining patient management strategies.

Clinical Best Practices

  • Utilize multiplex immunoassay and ELISA for cytokine quantification in GEP-NETs.
  • Consider the impact of comorbidities and socio-demographic factors on cytokine levels.

Related Resources & Content

Original Source(s)

Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer

  • by Agata Świętek, Joanna K. Strzelczyk, Dorota Hudy, Zenon P. Czuba, Karolina Snopek-Miśta, Mariusz Kryj, Katarzyna Kuśnierz, Marcin Zeman, Malgorzata Oczko-Wojciechowska, Daria Handkiewicz-Junak, Janusz Strzelczyk

  • July 2, 2026

Related Content

Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer

The plasmacytoid dendritic cell paradox in cancer: impaired type I interferon responses in a nucleic acid–rich tumor microenvironment

ERCC6L in human cancers: oncogenic functions, molecular mechanisms, and clinical implications as a prognostic biomarker and therapeutic target